A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness Under the Test-Negative Design: Analysis of Québec Administrative Data

被引:0
|
作者
Jiang, Cong [1 ]
Talbot, Denis [2 ]
Carazo, Sara [3 ]
Schnitzer, Mireille E. [1 ]
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[2] Univ Laval, Dept Med Sociale & Prevent, Quebec City, PQ, Canada
[3] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada
基金
加拿大健康研究院;
关键词
doubly robust; efficiency bounds; machine learning; outcome-dependent sampling; sample splitting; SENSITIVITY-ANALYSIS; INFLUENZA; CALCULUS; BIAS;
D O I
10.1002/sim.70025
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The test-negative design (TND), which is routinely used for monitoring seasonal flu vaccine effectiveness (VE), has recently become integral to COVID-19 vaccine surveillance, notably in Qu & eacute;bec, Canada. Some studies have addressed the identifiability and estimation of causal parameters under the TND, but efficiency bounds for nonparametric estimators of the target parameter under the unconfoundedness assumption have not yet been investigated. Motivated by the goal of improving adjustment for measured confounders when estimating COVID-19 VE among community-dwelling people aged >= 60$$ \ge 60 $$ years in Qu & eacute;bec, we propose a one-step doubly robust and locally efficient estimator called TNDDR (TND doubly robust), which utilizes cross-fitting (sample splitting) and can incorporate machine learning techniques to estimate the nuisance functions and thus improve control for measured confounders. We derive the efficient influence function (EIF) for the marginal expectation of the outcome under a vaccination intervention, explore the von Mises expansion, and establish the conditions for n$$ \sqrt{n} $$-consistency, asymptotic normality, and double robustness of TNDDR. The proposed estimator is supported by both theoretical and empirical justifications.
引用
收藏
页数:25
相关论文
共 50 条
  • [31] Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States
    Turbyfill, Caitlin
    Adams, Katherine
    Tenforde, Mark W.
    Murray, Nancy L.
    Gaglani, Manjusha
    Ginde, Adit A.
    McNeal, Tresa
    Ghamande, Shekhar
    Douin, David J.
    Talbot, H. Keipp
    Casey, Jonathan D.
    Mohr, Nicholas M.
    Zepeski, Anne
    Shapiro, Nathan I.
    Gibbs, Kevin W.
    Files, D. Clark
    Hager, David N.
    Shehu, Arber
    Prekker, Matthew E.
    Frosch, Anne E.
    Exline, Matthew C.
    Gong, Michelle N.
    Mohamed, Amira
    Johnson, Nicholas J.
    Srinivasan, Vasisht
    Steingrub, Jay S.
    Peltan, Ithan D.
    Brown, Samuel M.
    Martin, Emily T.
    Lauring, Adam S.
    Khan, Akram
    Busse, Laurence W.
    Lohuis, Caitlin C. ten
    Duggal, Abhijit
    Wilson, Jennifer G.
    Gordon, Alexandra June
    Qadir, Nida
    Chang, Steven Y.
    Mallow, Christopher
    Rivas, Carolina
    Kwon, Jennie H.
    Halasa, Natasha
    Chappell, James D.
    Grijalva, Carlos G.
    Rice, Todd W.
    Stubblefield, William B.
    Baughman, Adrienne
    Rhoads, Jillian P.
    Lindsell, Christopher J.
    Hart, Kimberly W.
    VACCINE, 2022, 40 (48) : 6979 - 6986
  • [32] Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands by medical risk condition: A test-negative case-control study
    Niessen, F. A.
    Bruijning-Verhagen, P. C. J. L.
    Bonten, M. J. M.
    Knol, M. J.
    VACCINE, 2024, 42 (15) : 3397 - 3403
  • [33] Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population- based test-negative case-control study
    Lee, Lennard Y. W.
    Starkey, Thomas
    Ionescu, Maria C.
    Little, Martin
    Tilby, Michael
    Tripathy, Arvind R.
    Mckenzie, Hayley S.
    Al-Hajji, Youssra
    Barnard, Matthew
    Benny, Liza
    Burnett, Alexander
    Cattell, Emma L.
    Charman, Jackie
    Clark, James J.
    Khan, Sam
    Ghafoor, Qamar
    Illsley, George
    Harper-Wynne, Catherine
    Hattersley, Rosie J.
    Lee, Alvin J. X.
    Leonard, Pauline C.
    Liu, Justin K. H.
    Forum, N. C. R. I. Consumer
    Pang, Matthew
    Pascoe, Jennifer S.
    Platt, James R.
    Potter, Vanessa A.
    Randle, Amelia
    Rigg, Anne S.
    Robinson, Tim M.
    Roques, Tom W.
    Roux, Rene L.
    Rozmanowski, Stefan
    Tuthill, Mark H.
    Watts, Isabella
    Williams, Sarah
    Iveson, Tim
    Lee, Siow Ming
    Middleton, Gary
    Middleton, Mark
    Protheroe, Andrew
    Fittall, Matthew W.
    Fowler, Tom
    Johnson, Peter
    LANCET ONCOLOGY, 2022, 23 (06): : 748 - 757
  • [34] Evaluation of the Real-World Effectiveness of Vaccines against COVID-19 at a Local Level: Protocol for a Test-Negative Case-Control Study
    Brazete, Catia
    Pinto, Marta
    Sa, Ligia
    Aguiar, Ana
    Alves, Filipe
    Duarte, Raquel
    VACCINES, 2022, 10 (05)
  • [35] Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case-control study
    de Munter, Leonie
    Meeraus, Wilhelmine
    Dwivedi, Akshat
    Mitratza, Marianna
    Wyndham-Thomas, Chloe
    Carty, Lucy
    Ouwens, Mario
    Hartig-Merkel, Wendy
    Drikite, Laura
    Rebry, Griet
    Casas, Irma
    Mira-Iglesias, Ainara
    Icardi, Giancarlo
    Otero-Romero, Susana
    Baumgartner, Sebastian
    Martin, Charlotte
    Holemans, Xavier
    ten Kate, Gerrit Luit
    Bollaerts, Kaatje
    Taylor, Sylvia
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2025,
  • [36] COVID-19 vaccine effectiveness and variants in Nepal: study protocol for a test-negative case-control study with SARS-CoV-2 genetic sequencing
    Bijukchhe, Sanjeev M.
    O'Reilly, Peter J.
    Theiss-Nyland, Katherine
    Gurung, Meeru
    Pokhrel, Bhishma
    Kelly, Sarah
    Acharya, Samita
    Maharjan, Shreekrishna
    Shrestha, Ashis
    Pandey, Bimal
    Lama, Mipsang
    Shrestha, Ira
    Voysey, Merryn
    Eordogh, Agnes
    Shrestha, Sonu
    Feng, Elaine Shuo
    Li, Grace
    Shah, Ganesh
    Pollard, Andrew J.
    Shrestha, Shrijana
    BMJ OPEN, 2023, 13 (04):
  • [37] Effectiveness of BNT162b2 and mRNA-1273 Vaccines against COVID-19 Infection: A Meta-Analysis of Test-Negative Design Studies
    Chang, Shuailei
    Liu, Hongbo
    Wu, Jian
    Xiao, Wenwei
    Chen, Sijia
    Qiu, Shaofu
    Duan, Guangcai
    Song, Hongbin
    Zhang, Rongguang
    VACCINES, 2022, 10 (03)
  • [38] Using a Machine Learning Approach to Monitor COVID-19 Vaccine Adverse Events (VAE) from Twitter Data
    Lian, Andrew T.
    Du, Jingcheng
    Tang, Lu
    VACCINES, 2022, 10 (01)
  • [39] Vaccine effectiveness of JCOVDEN single-dose against COVID-19 hospitalisation in Europe: An id.DRIVE test-negative case-control study
    Wyndham-Thomas, Chloe
    Newbern, E. Claire
    Mira-Iglesias, Ainara
    Dwivedi, Akshat
    Sanchez, Alejandro Orrico
    Anton, Andres
    Martin, Charlotte
    Icardi, Giancarlo
    Casas, Irma
    Ngew, Kok Yew
    Drikite, Laura
    de Munter, Leonie
    Kate, Gerrit Luit ten
    Vroom, Nikki
    Baumgartner, Sebastian
    Otero-Romero, Susana
    Holemans, Xavier
    Bollaerts, Kaatje
    Praet, Nicolas
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2025, 18 (05)
  • [40] Machine learning approach for data analysis and predicting coronavirus using COVID-19 India dataset
    Singh S.
    Ramkumar K.R.
    Kukkar A.
    International Journal of Business Intelligence and Data Mining, 2023, 24 (01) : 47 - 73